Business Description
Hisamitsu Pharmaceutical Co Inc
NAICS : 325412
ISIN : JP3784600003
Share Class Description:
TSE:4530: Ordinary SharesCompare
Compare
Traded in other countries / regions
4530.JapanHTSUY.USAHPX.Germany IPO Date
1962-09-01Description
Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 109.88 | |||||
| Equity-to-Asset | 0.78 | |||||
| Debt-to-EBITDA | 0.05 | |||||
| Interest Coverage | 510.26 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 4.63 | |||||
| Beneish M-Score | -2.4 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 9.5 | |||||
| 3-Year EBITDA Growth Rate | 16.7 | |||||
| 3-Year EPS without NRI Growth Rate | 18.5 | |||||
| 3-Year FCF Growth Rate | 42.2 | |||||
| 3-Year Book Growth Rate | 4.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 11.57 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 4.87 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 60.97 | |||||
| 9-Day RSI | 52.78 | |||||
| 14-Day RSI | 51.24 | |||||
| 3-1 Month Momentum % | 10.62 | |||||
| 6-1 Month Momentum % | 16.08 | |||||
| 12-1 Month Momentum % | -4.85 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.53 | |||||
| Quick Ratio | 3.14 | |||||
| Cash Ratio | 2.09 | |||||
| Days Inventory | 121.63 | |||||
| Days Sales Outstanding | 107.8 | |||||
| Days Payable | 57.53 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.03 | |||||
| Dividend Payout Ratio | 0.48 | |||||
| 3-Year Dividend Growth Rate | 0.6 | |||||
| Forward Dividend Yield % | 2.04 | |||||
| 5-Year Yield-on-Cost % | 2.09 | |||||
| 3-Year Average Share Buyback Ratio | 2.5 | |||||
| Shareholder Yield % | 2.05 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 56.42 | |||||
| Operating Margin % | 9.17 | |||||
| Net Margin % | 9.76 | |||||
| FCF Margin % | 3.43 | |||||
| ROE % | 5.45 | |||||
| ROA % | 4.32 | |||||
| ROIC % | 5.12 | |||||
| 3-Year ROIIC % | 4.71 | |||||
| ROC (Joel Greenblatt) % | 26.95 | |||||
| ROCE % | 7.22 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 21.94 | |||||
| Forward PE Ratio | 19.4 | |||||
| PE Ratio without NRI | 24.11 | |||||
| Shiller PE Ratio | 20.29 | |||||
| PS Ratio | 2.14 | |||||
| PB Ratio | 1.15 | |||||
| Price-to-Tangible-Book | 1.17 | |||||
| Price-to-Free-Cash-Flow | 64.2 | |||||
| Price-to-Operating-Cash-Flow | 18.19 | |||||
| EV-to-EBIT | 9.24 | |||||
| EV-to-EBITDA | 9.24 | |||||
| EV-to-Revenue | 1.27 | |||||
| EV-to-FCF | 36.75 | |||||
| Price-to-GF-Value | 0.87 | |||||
| Price-to-Projected-FCF | 0.98 | |||||
| Price-to-Median-PS-Value | 0.75 | |||||
| Price-to-Graham-Number | 1.12 | |||||
| Price-to-Net-Current-Asset-Value | 2.4 | |||||
| Price-to-Net-Cash | 6.83 | |||||
| Earnings Yield (Greenblatt) % | 10.81 | |||||
| FCF Yield % | 1.64 | |||||
| Forward Rate of Return (Yacktman) % | -1.97 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hisamitsu Pharmaceutical Co Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 150,185 | ||
| EPS (TTM) (円) | 195.74 | ||
| Beta | 0.09 | ||
| 3-Year Sharpe Ratio | 0.17 | ||
| 3-Year Sortino Ratio | 0.3 | ||
| Volatility % | 24.96 | ||
| 14-Day RSI | 51.24 | ||
| 14-Day ATR (円) | 66.409441 | ||
| 20-Day SMA (円) | 4246.3 | ||
| 12-1 Month Momentum % | -4.85 | ||
| 52-Week Range (円) | 3600 - 4622 | ||
| Shares Outstanding (Mil) | 73.34 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hisamitsu Pharmaceutical Co Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hisamitsu Pharmaceutical Co Inc Stock Events
| Event | Date | Price (円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hisamitsu Pharmaceutical Co Inc Frequently Asked Questions
What is Hisamitsu Pharmaceutical Co Inc(TSE:4530)'s stock price today?
The current price of TSE:4530 is 円4265.00. The 52 week high of TSE:4530 is 円4622.00 and 52 week low is 円3600.00.
When is next earnings date of Hisamitsu Pharmaceutical Co Inc(TSE:4530)?
The next earnings date of Hisamitsu Pharmaceutical Co Inc(TSE:4530) is .
Does Hisamitsu Pharmaceutical Co Inc(TSE:4530) pay dividends? If so, how much?
The Dividend Yield %  of Hisamitsu Pharmaceutical Co Inc(TSE:4530) is 2.03% (As of Today), Highest Dividend Payout Ratio of Hisamitsu Pharmaceutical Co Inc(TSE:4530) was 0.75. The lowest was 0.35. And the median was 0.38. The  Forward Dividend Yield % of Hisamitsu Pharmaceutical Co Inc(TSE:4530) is 2.04%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers